Beth A. Weaver
Cell Biology · 2005–2014
A researcher in the Science corpus: 3 papers; trusts 4 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Cell Biology — 28 citations into it; #1,478 of 2,073 by trust here, #866 by citations
- Molecular Biology — 25 citations into it
- Oncology — 12 citations into it; #1,521 of 1,698 by trust here, #1,240 by citations
Whom Beth A. Weaver trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Beth A. Weaver overall
Papers from Beth A. Weaver's perspective
Ordered by how strongly the researchers Beth A. Weaver trusts endorse each paper. Same corpus, a different order for every researcher.
- Microtubules as a target for anticancer drugs (Nature Reviews. Cancer)
- Merotelic Kinetochore Orientation Is a Major Mechanism of Aneuploidy in Mitotic Mammalian Tissue Cells (Journal of Cell Biology)
- Aurora-kinase inhibitors as anticancer agents (Nature Reviews. Cancer)
- On the road to cancer: aneuploidy and the mitotic checkpoint (Nature Reviews. Cancer)
- The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore–microtubule attachment and in maintaining the spindle assembly checkpoint (Journal of Cell Biology)
- Evidence that the Ipl1-Sli15 (Aurora kinase-INCENP) complex promotes chromosome bi-orientation by altering kinetochore-spindle pole connections. (Cell)
- From polyploidy to aneuploidy, genome instability and cancer (Nature reviews. Molecular cell biology)
- Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint. (Developmental Cell)
- Centrosome aberrations: cause or consequence of cancer progression? (Nature Reviews. Cancer)
- A role for the Adenomatous Polyposis Coli protein in chromosome segregation (Nature Cell Biology)
Their papers
- On the road to cancer: aneuploidy and the mitotic checkpoint (2005) — 1,237 citations
- How Taxol/paclitaxel kills cancer cells (2014) — 1,383 citations
- Aneuploidy acts both oncogenically and as a tumor suppressor. (2007) — 768 citations